CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas.

MLA

Hickman, Richard A., et al. “CDKN2A/B Mutations and Allele-Specific Alterations Stratify Survival Outcomes in IDH-Mutant Astrocytomas.” Acta Neuropathologica, vol. 146, no. 6, Dec. 2023, pp. 845–47. EBSCOhost, https://doi.org/10.1007/s00401-023-02639-0.

APA

Hickman, R. A., Gedvilaite, E., Ptashkin, R., Reiner, A. S., Cimera, R., Nandakumar, S., Price, A., Vanderbilt, C., Fahy, T., Young, R. J., Miller, A. M., Mellinghoff, I. K., Rosenblum, M. K., Ladanyi, M., Arcila, M. E., Zhang, Y., Brannon, A. R., & Bale, T. A. (2023). CDKN2A/B mutations and allele-specific alterations stratify survival outcomes in IDH-mutant astrocytomas. Acta Neuropathologica, 146(6), 845–847. https://doi.org/10.1007/s00401-023-02639-0

Chicago

Hickman, Richard A, Erika Gedvilaite, Ryan Ptashkin, Anne S Reiner, Robert Cimera, Subhiksha Nandakumar, Adam Price, et al. 2023. “CDKN2A/B Mutations and Allele-Specific Alterations Stratify Survival Outcomes in IDH-Mutant Astrocytomas.” Acta Neuropathologica 146 (6): 845–47. doi:10.1007/s00401-023-02639-0.